These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2273645)
1. Effects of KT-362, a new calcium release blocker, on vascular selectivity and hemodynamic actions in anesthetized dogs. Wakabayashi S; Mochizuki S; Tomiyama A; Shibata S Jpn J Pharmacol; 1990 Sep; 54(1):23-32. PubMed ID: 2273645 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and electrocardiographic actions of the new intracellular calcium antagonist, KT-362, in the conscious dog. Hartman JC; Al-Wathiqui MH; Brooks HL; Gross GJ; Warltier DC Pharmacology; 1988; 37(6):376-84. PubMed ID: 3244744 [TBL] [Abstract][Full Text] [Related]
3. Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression. Buljubasic N; Marijic J; Stowe DF; Gross GJ; Kampine JP; Bosnjak ZJ J Cardiovasc Pharmacol; 1991 Oct; 18(4):594-604. PubMed ID: 1724538 [TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium. Farber NE; Gross GJ J Pharmacol Exp Ther; 1989 Jan; 248(1):39-43. PubMed ID: 2536431 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs. Murata S; Kikkawa K; Yabana H; Nagao T Arzneimittelforschung; 1988 Apr; 38(4):521-5. PubMed ID: 3401267 [TBL] [Abstract][Full Text] [Related]
6. Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist. Shibata S; Wakabayashi S; Satake N; Hester RK; Ueda S; Tomiyama A J Pharmacol Exp Ther; 1987 Jan; 240(1):16-22. PubMed ID: 3100766 [TBL] [Abstract][Full Text] [Related]
7. Effect of KT-362, a putative intracellular calcium antagonist, on norepinephrine-induced contractions and inositol monophosphate accumulation in canine femoral artery. Eskinder H; Hillard CJ; Wilke RA; Gross GJ J Cardiovasc Pharmacol; 1989 Mar; 13(3):502-7. PubMed ID: 2471898 [TBL] [Abstract][Full Text] [Related]
8. Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs. Pelc LR; Farber NE; Warltier DC; Gross GJ J Cardiovasc Pharmacol; 1989 Apr; 13(4):586-93. PubMed ID: 2470996 [TBL] [Abstract][Full Text] [Related]
9. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem. Farber NE; Gross GJ J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718 [TBL] [Abstract][Full Text] [Related]
10. Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca2+ level in the rat aorta. Sakata K; Karaki H Br J Pharmacol; 1991 Jan; 102(1):174-8. PubMed ID: 1710524 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker. Gerold M; Eigenmann R; Haeusler G J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938 [TBL] [Abstract][Full Text] [Related]
12. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem. Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336 [TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues. Mecca TE; Love SD J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs. Kaburaki M; Narita H; Yabana H; Karasawa T; Doi H; Murata S J Cardiovasc Pharmacol; 1998 Feb; 31(2):240-7. PubMed ID: 9475265 [TBL] [Abstract][Full Text] [Related]
16. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
17. Myocardial lactate release after intracoronary verapamil application in humans: acute effects of intracoronary verapamil on systemic and coronary hemodynamics, myocardial metabolism, and norepinephrine levels. Oldenburg O; Eggebrecht H; Gutersohn A; Schaar J; Brauck K; Haude M; Erbel R; Baumgart D Cardiovasc Drugs Ther; 2001 Jan; 15(1):55-61. PubMed ID: 11504164 [TBL] [Abstract][Full Text] [Related]
18. Effects of four calcium channel blockers on central cardiovascular control. Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230 [TBL] [Abstract][Full Text] [Related]
19. Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties. Hof RP Am J Cardiol; 1987 Jan; 59(3):43B-51B. PubMed ID: 2880495 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of nicardipine in anesthetized open-chest dogs in the absence and presence of beta-adrenergic receptor blockade: a comparison with nifedipine and verapamil. Bongrani S; Razzetti R; Schiantarelli P J Cardiovasc Pharmacol; 1985; 7(5):899-905. PubMed ID: 2413298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]